[1]
“Tapinarof Cream 1% Once Daily for Plaque Psoriasis: Long-Term Extension Trial of a Novel Therapeutic Aryl Hydrocarbon Receptor Modulating Agent”, J of Skin, vol. 5, no. 6, p. s35, Nov. 2021, doi: 10.25251/skin.5.supp.35.